According to the Wall Street Journal, “Powerful members of Congress want to remake the Food and Drug Administration by giving it broad powers to levy fines, order drug recalls and restrict drug-industry advertising. Leading the drive are Rep. John Dingell (D., Mich.) and his longtime friend in Congress, Sen. Chuck Grassley (R., Iowa).”
“The lawmakers say an FDA restructuring should build a much taller wall between the agency and the industry it regulates. The FDA would gain authority to recall drugs, which it can't do today, and to impose significant fines on drug companies for safety violations. The lawmakers also want the FDA to inspect generic-drug makers before approving a new product. Perhaps most importantly, they want the next president to appoint a tough FDA commissioner completely independent from the industry.”
Can anyone out there think of even one drug that the FDA wanted recalled that was not “voluntarily” recalled?
No – I didn’t think so.
(Also, isn't the FDA already an entirely independent government agency?)FDA officials "are too cozy with the companies they regulate," Mr. Grassley said, adding that new leadership must "fix the culture."
What does “too cozy” mean? Really, what does it mean?
Senator Grassley believes the FDA Office of New Drugs, which he said has been compromised by its relations with industry lobbyists, among them former top FDA officials.”
And what does that mean? Any evidence to back up such blowhard accusations?
Too boot, here’s some really shoddy reporting by the Journal’s Alicia Mundy,
“Some current and former FDA safety reviewers have opened a whistleblower Web site to air their concerns that FDA leaders are pushing them to approve some drugs”
She is referring to www.thoreau-fda.com/index.php.
Oops.
But who needs facts when you have red-hot rhetoric and a gullible reporter who's willing to take a leak anywhere?
